These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 28493050

  • 1. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
    Hofni A, Shehata Messiha BA, Mangoura SA.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
    [Abstract] [Full Text] [Related]

  • 2. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D, Gao J, Bi X, He H, Shi X, Weng S, Chen Y, Yang Y, Ye Y, Fu G.
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [Abstract] [Full Text] [Related]

  • 3. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, Hafezi-Moghadam A, Ishibashi T.
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [Abstract] [Full Text] [Related]

  • 4. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
    Xie Y, Song T, Huo M, Zhang Y, Zhang YY, Ma ZH, Wang N, Zhang JP, Chu L.
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
    [Abstract] [Full Text] [Related]

  • 5. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
    Gojo A, Utsunomiya K, Taniguchi K, Yokota T, Ishizawa S, Kanazawa Y, Kurata H, Tajima N.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):242-7. PubMed ID: 17511984
    [Abstract] [Full Text] [Related]

  • 6. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA, Darwish HA, Abdelsalam RM, Amin HA.
    Mol Neurobiol; 2016 Aug 30; 53(6):3927-3938. PubMed ID: 26169112
    [Abstract] [Full Text] [Related]

  • 7. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
    Li WJ, Park K, Paick JS, Kim SW.
    J Sex Med; 2011 Feb 30; 8(2):400-10. PubMed ID: 20233282
    [Abstract] [Full Text] [Related]

  • 8. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
    Zhou H, Fang C, Zhang L, Deng Y, Wang M, Meng F.
    Chin Med J (Engl); 2014 Feb 30; 127(2):225-31. PubMed ID: 24438608
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Tratsiakovich Y, Kiss A, Gonon AT, Yang J, Sjöquist PO, Pernow J.
    Diab Vasc Dis Res; 2017 May 30; 14(3):236-245. PubMed ID: 28183205
    [Abstract] [Full Text] [Related]

  • 10. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
    Yokota T, Utsunomiya K, Taniguchi K, Gojo A, Kurata H, Tajima N.
    Jpn J Ophthalmol; 2007 May 30; 51(6):424-30. PubMed ID: 18158592
    [Abstract] [Full Text] [Related]

  • 11. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
    Sezen SF, Lagoda G, Musicki B, Burnett AL.
    J Sex Med; 2014 Sep 30; 11(9):2164-71. PubMed ID: 24919622
    [Abstract] [Full Text] [Related]

  • 12. Rho kinase inhibition by fasudil exerts antioxidant effects in hypercholesterolemic rats.
    Ma Z, Zhang J, Ji E, Cao G, Li G, Chu L.
    Clin Exp Pharmacol Physiol; 2011 Oct 30; 38(10):688-94. PubMed ID: 21711379
    [Abstract] [Full Text] [Related]

  • 13. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
    Shah DI, Singh M.
    Mol Cell Biochem; 2006 Feb 30; 283(1-2):191-9. PubMed ID: 16444602
    [Abstract] [Full Text] [Related]

  • 14. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW, Park CH, Kim IJ, Bae EH, Ma SK, Lee JU, Kim SW.
    J Pharmacol Exp Ther; 2011 Jul 30; 338(1):271-9. PubMed ID: 21474569
    [Abstract] [Full Text] [Related]

  • 15. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
    Waddingham MT, Edgley AJ, Astolfo A, Inagaki T, Fujii Y, Du CK, Zhan DY, Tsuchimochi H, Yagi N, Kelly DJ, Shirai M, Pearson JT.
    Cardiovasc Diabetol; 2015 Jul 22; 14():92. PubMed ID: 26194354
    [Abstract] [Full Text] [Related]

  • 16. Effect of fasudil on macrovascular disorder-induced endothelial dysfunction.
    Shah DI, Singh M.
    Can J Physiol Pharmacol; 2006 Jul 22; 84(8-9):835-45. PubMed ID: 17111028
    [Abstract] [Full Text] [Related]

  • 17. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
    Pearson JT, Jenkins MJ, Edgley AJ, Sonobe T, Joshi M, Waddingham MT, Fujii Y, Schwenke DO, Tsuchimochi H, Yoshimoto M, Umetani K, Kelly DJ, Shirai M.
    Cardiovasc Diabetol; 2013 Aug 01; 12():111. PubMed ID: 24059472
    [Abstract] [Full Text] [Related]

  • 18. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
    Anegawa G, Kawanaka H, Yoshida D, Konishi K, Yamaguchi S, Kinjo N, Taketomi A, Hashizume M, Shimokawa H, Maehara Y.
    Hepatology; 2008 Mar 01; 47(3):966-77. PubMed ID: 18167063
    [Abstract] [Full Text] [Related]

  • 19. The Rho-kinase inhibitor fasudil restores normal motor nerve conduction velocity in diabetic rats by assuring the proper localization of adhesion-related molecules in myelinating Schwann cells.
    Kanazawa Y, Takahashi-Fujigasaki J, Ishizawa S, Takabayashi N, Ishibashi K, Matoba K, Kawanami D, Yokota T, Tajima N, Utsunomiya K.
    Exp Neurol; 2013 Sep 01; 247():438-46. PubMed ID: 23337773
    [Abstract] [Full Text] [Related]

  • 20. Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats.
    Jin J, Peng C, Wu SZ, Chen HM, Zhang BF.
    Acta Pharmacol Sin; 2015 Jul 01; 36(7):831-40. PubMed ID: 25937636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.